We limit data available in the Overview Report for users who do not have Powerpack
Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Target Price Range
Recommendation Rating
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 70.16 | 78.63 | 93.32 | 81.33 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 105.28 | 100.52 | 113.50 | 116.46 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,250 | 5,550 | 5,750 | 5,550 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.02 | 1.06 | 1.06 | 1.12 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,375.60 | 5,867.90 | 6,107.10 | 6,203.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 41.86% | 44.11% | 45.69% | 44.73% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 523.30 | 967.40 | 756.30 | 956.90 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.73% | 16.49% | 12.38% | 15.43% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 413.90 | 755.60 | 585.30 | 736.80 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 219.00 | 225.20 | 239.10 | 247.40 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.13 | 23.96 | 24.99 | 25.56 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 1.70 | 3.09 | 2.39 | 3.04 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.64 | 4.21 | 4.73 | 5.01 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.74) | (0.91) | (0.71) | (0.50) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.91 | 3.30 | 4.02 | 4.50 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.37 | 15.74 | 17.84 | 16.49 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 242.90 | 244.90 | 244.40 | 242.70 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 48.25 | 30.70 | 43.63 | 27.67 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.71 | 3.95 | 4.19 | 3.28 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.71 | 6.01 | 5.87 | 5.08 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.15 | 4.30 | 4.39 | 3.57 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.61 | 31.25 | 27.30 | 20.27 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 885.20 | 1,030.60 | 1,156.20 | 1,215.40 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (178.80) | (223.50) | (173.20) | (122.40) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 706.40 | 807.10 | 983.00 | 1,093.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 212.10 | 107.70 | 924.70 | 99.30 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,673.50 | 2,406.00 | 2,204.60 | 2,205.10 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,403.20 | 2,061.50 | 1,240.50 | 1,796.10 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,489.90 | 3,855.40 | 4,360.80 | 4,002.20 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.07% | 8.93% | 6.71% | 8.28% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.34% | 11.17% | 9.01% | 11.62% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.31% | 20.57% | 14.25% | 17.62% | — | — | — |
ROE
|
Analyst Commentary (Summary)
Church & Dwight Co., Inc. (CHD) Latest News
21 Sep
Two dividend stocks stand out for a five-year hold: Church & Dwight (CHD) and Costco (COST). CHD is a steady, no-frills consumer-goods portfolio with mid-single-digit organic growth; in Q1 2026 organic sales rose about 5% with over-5% volume growth, and management guides 4–5% full-year organic growth and roughly $1.175B cash from operations, supporting dividends and bolt-on acquisitions. Q2 continued the pattern, with 5.8% organic growth and margin expansion potential. COST blends retail scale with a growing membership base; the board raised the quarterly dividend from $1.30 to $1.47 in April 2026, funded by strong cash flow from 930+ warehouses, though earnings expectations warn of margin pressure from higher transport costs and investments. The two offer durable demand, strategic acquisitions, and growing income suitable for a buy-and-hold stance over the next five years. Stable, mid-single-digit growth and dividend visibility support long-term value, but no major catalysts are identified.
9 Aug
Church & Dwight Co. faced five key analyst questions in its Q2 earnings call focused on sales trends, margin pressures, acquisition integration, category competition, and long-term growth targets. Q2 earnings questions highlight operational and competitive issues that can moderately shift near-term investor sentiment and stock movement.
7 Aug
Church & Dwight Co., Inc. (CHD) held its Q2 2026 earnings call discussing quarterly financial results, performance metrics and forward outlook. Q2 2026 earnings call transcript provides detailed financial results and guidance with direct potential to shift investor sentiment and stock trajectory.
3 Aug
Church & Dwight reported strong Q2 organic sales growth that reinforces brand momentum, according to Morgan Stanley. Positive Q2 sales growth note from Morgan Stanley may support moderate gains in investor sentiment and near-term performance.
1 Aug
Church & Dwight Co., Inc. held its Q2 2026 earnings call covering financial results, operational updates and outlook. Q2 earnings provide financial updates that moderately influence near-term sentiment without major strategic shifts.
31 Jul
Church & Dwight Co Inc posted Q2 2026 earnings with organic sales surging 5%. 5% organic sales surge signals strong growth likely to lift stock performance and investor outlook.
Church & Dwight (NYSE:CHD) reports Q2 CY2026 sales exceeding expectations. Unexpected Q2 sales beat signals stronger performance that can shift CHD stock trajectory and investor sentiment.
Church & Dwight Q2 earnings call highlights include company financial results, segment performance, and forward outlook. Q2 earnings data and guidance offer moderate insight into near-term financial trajectory.
Church & Dwight reported Q2 earnings matching estimates with sales beating forecasts on strong organic growth. Q2 sales beat on organic growth signals moderate short-term revenue upside without shifting long-term trajectory.
Church & Dwight Co., Inc. reported strong second quarter results. Strong second quarter results moderately influence CHD financial performance and market perception.
30 Jul
Church & Dwight (CHD) Q2 earnings preview outlines expected revenue, margins, organic growth and guidance updates for the quarter. Q2 earnings results and guidance can shift CHD valuation and short-term market views.
27 Jul
Reynolds faces growth drivers and risks in 2026 that investors should monitor closely. Growth drivers and risks in 2026 may moderately affect operations and market position.
23 Jul
UBS analysts state Church & Dwight Co. is capable of delivering another quarter of organic sales upside. Positive UBS outlook on organic sales growth may moderately influence CHD investor sentiment and near-term performance.
14 Jul
HELE stock outlook improves as brand momentum starts to rebuild. Rebuilding brand momentum signals moderately improved sales trajectory and investor sentiment for the company.
1 Jun
RBC affirms Church & Dwight Co., Inc. (CHD) remains well positioned for growth despite macroeconomic headwinds. RBC positive stance signals resilience that may moderately lift investor sentiment and share performance.
26 May
PG and CHD face direct comparison to assess which holds stronger growth prospects within consumer staples. Growth comparison between CHD and peer may moderately shift investor sentiment on CHD trajectory.
11 May
Church & Dwight's Q1 earnings call featured five must-read analyst questions addressing critical aspects of performance, strategy, and outlook. Analyst questions from Q1 earnings call spotlight key financial and strategic concerns with moderate potential to influence investor sentiment.
Church & Dwight (NYSE:CHD) demonstrates performance stronger than its reported earnings indicate, driven by robust underlying business metrics and growth momentum. Performance exceeding earnings highlights improved financial health and moderate boost to investor sentiment.
8 May
RBC Capital praises Church & Dwight (CHD) for delivering an impressive quarter. Analyst endorsement of strong quarterly results may boost investor sentiment and near-term financial perception.
4 May
Church & Dwight posted impressive Q1 results driven by volume-led organic growth, according to RBC analysts. Impressive Q1 with volume-driven organic growth boosts financial performance and investor sentiment moderately.
3 May
Investors react positively to Church & Dwight (CHD) Q1 earnings beat, margin gains, and affirmed dividend. Q1 earnings beat, margin gains, and dividend affirmation signal strong financial health and boost investor sentiment significantly.
Church & Dwight's Q1 top-line revenue stayed flat, offset by organic growth and distribution gains. Flat Q1 revenue balanced by organic growth and distribution gains points to moderate influence on financial performance.
2 May
Church & Dwight Co Inc (CHD) reported strong organic growth in Q1 2026 earnings call highlights. Strong organic growth in Q1 2026 drives significant positive impact on CHD's financial trajectory and investor sentiment.
1 May
Church & Dwight Co., Inc. (CHD) Q1 earnings beat expectations, driven by organic sales growth and margin expansion. Q1 earnings beat via organic sales growth and margin gains boosts financial performance and investor confidence significantly.
Church & Dwight Co., Inc. (CHD) Q1 earnings and revenues surpassed analyst estimates. Q1 earnings beat signals strong financial performance, likely driving positive stock reaction and outlook.
Church & Dwight (NYSE:CHD) reported better-than-expected sales for Q1 CY2026. Better-than-expected Q1 sales indicate strong financial performance, likely enhancing investor confidence and stock trajectory.
Church & Dwight Co., Inc. (CHD) reported Q1 2026 results. Q1 earnings report reveals financial performance and guidance impacting stock trajectory and investor sentiment.
Church & Dwight Co., Inc. (CHD) Q1 2026 earnings call summary covers financial results, sales growth, profitability, guidance, and strategic initiatives. Quarterly earnings summaries detail financial performance and forward guidance, moderately influencing investor sentiment and stock trajectory.
Church & Dwight Co., Inc. (CHD) shared Q1 earnings call highlights, covering financial results, revenue growth, margin improvements, guidance updates, and strategic initiatives in consumer products. Q1 earnings highlights reveal financial performance and outlook, moderately influencing market sentiment and stock trajectory.
Church & Dwight (CHD) Q1 earnings key metrics compared to estimates, highlighting performance in sales, EPS, and margins versus analyst expectations. Q1 earnings metrics versus estimates moderately influence financial performance and investor sentiment without fundamentally altering long-term trajectory.
Church & Dwight Co., Inc. (CHD) exemplifies resilient growth in consumer staples, transforming everyday essentials like Arm & Hammer, Trojan, and OxiClean into a powerhouse portfolio. Revenue has surged 75% from $3.49 billion in 2016 to $6.11 billion in 2024, with projections hitting $6.65 billion by 2028 at a 5.7% CAGR, driven by organic expansion, strategic acquisitions like TheraBreath, and megatrends in sustainability, pet humanization, and premium oral care. Despite COVID supply disruptions and 2022 inflation, CHD maintains robust gross margins around 45%, high revenue per employee over $1.06 million, and strong cash flows, with free cash flow per share up 71% to $4.02.
Profitability shines through volatility: EPS is forecasted to reach $4.39 by 2028 (146% growth from 2016), ROE at 14.3% in 2024 exceeds peers, and the balance sheet boasts doubled shareholders’ equity and net debt down 48%. Stock has appreciated 200% since 2016, trading at attractive EV/FCF of 27.3, supported by a 29-year dividend streak and share buybacks.
Analysts project upbeat upside from pet care gains, international expansion (20%+ of revenue), and ESG-driven innovations, with recent executive insider buys signaling confidence amid net selling. Risks like input costs are buffered by operational leverage, positioning CHD for 10-12% annual returns— a defensive growth story primed for the next decade.